Rafael S. Rios
Wenzhou, 325000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Hepatocyte apoptosis fragment product cytokeratin-18 M30 level and non-alcoholic steatohepatitis risk diagnosis: an international registry study.
Journal: Chinese medical journal
Published: February 27, 2023
Glycemic control predicts the risk of hepatic fibrosis in biopsy-proven NAFLD: a possible mediating role for leukemia inhibitory factor?
Journal: iLIVER
Published: March 07, 2022
LEARN algorithm: a novel option for predicting non-alcoholic steatohepatitis.
Journal: Hepatobiliary surgery and nutrition
Published: December 12, 2021
Non-alcoholic steatohepatitis and risk of hepatocellular carcinoma.
Journal: Chinese medical journal
Published: December 02, 2021
Histological Characteristics of Non-alcoholic Steatohepatitis in NAFLD Patients With Low Degree of Hepatocyte Apoptosis.
Journal: The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology
Published: October 05, 2021
Protective association of Klotho rs495392 gene polymorphism against hepatic steatosis in non-alcoholic fatty liver disease patients.
Journal: Clinical and molecular hepatology
Published: September 20, 2021
J-shaped relationship between serum zinc levels and the severity of hepatic necro-inflammation in patients with MAFLD.
Journal: Nutrition, metabolism, and cardiovascular diseases : NMCD
Published: August 08, 2021
PNPLA3 rs738409 C>G Variant Influences the Association Between Visceral Fat and Significant Fibrosis in Biopsy-proven Nonalcoholic Fatty Liver Disease.
Journal: Journal of clinical and translational hepatology
Published: July 16, 2021
Sex influences the association between appendicular skeletal muscle mass to visceral fat area ratio and non-alcoholic steatohepatitis in patients with biopsy-proven non-alcoholic fatty liver disease.
Journal: The British journal of nutrition
Published: June 28, 2021
Telomerase: a key player in the pathogenesis of non-alcoholic fatty liver disease?
Journal: Expert review of gastroenterology & hepatology
Published: March 12, 2021
Interaction of SAMM50-rs738491, PARVB-rs5764455 and PNPLA3-rs738409 Increases Susceptibility to Nonalcoholic Steatohepatitis.
Journal: Journal of clinical and translational hepatology
Published: February 09, 2021
A novel radiomics signature based on T2-weighted imaging accurately predicts hepatic inflammation in individuals with biopsy-proven nonalcoholic fatty liver disease: a derivation and independent validation study.
Journal: Hepatobiliary surgery and nutrition
Published: January 18, 2021
Last Updated: 09/26/2026